mudeye, copy of post 154011 author - stolwyk, plenty more by him on this subject too.
The early Nov result of Phase II is less than 4 weeks away.
I am not too concerned about the FDA approval at this stage. That date was set some time ago but may have changed perhaps as the trial took a week longer than envisaged. Then again, a discusion could lead to Approval later.
Phase II results have priority and we are getting pretty close to it. The market wil need to move to the expectations set at that time.
I would expect one large Announcement or two, the latter setting out the progress on Commercialisation.
Say, one on the Results and another "Letter to Shareholders".
Expect to read more about EPT later: progress on delivery systems.
IMHO, this is a good time to be in EPT.
Gerry
http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=58902&sym=EPT#149290
up 19% this week, page-3
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.62 |
Change
0.050(0.37%) |
Mkt cap ! $681.8M | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.05 | $13.51 | $1.938M | 140.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 351 | $13.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.62 | 94 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |